Clinical practice guidelines for the diagnosis and treatment of cutaneous leishmaniasis in Turkey

Basit Öğe Kaydı
dc.contributor.authorUzun, Soner
dc.contributor.authorGurel, Mehmet S.
dc.contributor.authorDurdu, Murat
dc.contributor.authorAkyol, Melih
dc.contributor.authorKaraman, Bilge Fettahlioglu
dc.contributor.authorAksoy, Mustafa
dc.contributor.authorAytekin, Sema
dc.date.accessioned2024-04-24T17:11:28Z
dc.date.available2024-04-24T17:11:28Z
dc.date.issued2018
dc.departmentDicle Üniversitesien_US
dc.description.abstractBackground Cutaneous leishmaniasis ( CL) is a vector- born parasitic disease characterized by various skin lesions that cause disfiguration if healed spontaneously. Although CL has been endemic for many years in the southern regions of Turkey, an increasing incidence in nonendemic regions is being observed due to returning travelers and, more recently, due to Syrian refugees. Thus far, a limited number of national guidelines have been proposed, but no common Turkish consensus has emerged. Objectives The aim of this study was to develop diagnostic and therapeutic guidelines for the management of CL in Turkey. Methods This guideline is a consensus text prepared by 18 experienced CL specialists who have been working for many years in areas where the disease is endemic. The Delphi method was used to determine expert group consensus. Initially, a comprehensive list of items about CL was identified, and consensus was built from feedback provided by expert participants from the preceding rounds. Results Evidence- based and expert- based recommendations through diagnostic and therapeutic algorithms according to local availability and conditions are outlined. Conclusion Because CL can mimic many other skin diseases, early diagnosis and early treatment are very important to prevent complications and spread of the disease. The fastest and easiest diagnostic method is the leishmanial smear. The most common treatment is the use of local or systemic pentavalent antimony compounds.en_US
dc.identifier.doi10.1111/ijd.14002
dc.identifier.endpage982en_US
dc.identifier.issn0011-9059
dc.identifier.issn1365-4632
dc.identifier.issue8en_US
dc.identifier.pmid29663351
dc.identifier.scopus2-s2.0-85046769103
dc.identifier.scopusqualityQ1
dc.identifier.startpage973en_US
dc.identifier.urihttps://doi.org/10.1111/ijd.14002
dc.identifier.urihttps://hdl.handle.net/11468/17544
dc.identifier.volume57en_US
dc.identifier.wosWOS:000437833900024
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofInternational Journal of Dermatology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleClinical practice guidelines for the diagnosis and treatment of cutaneous leishmaniasis in Turkeyen_US
dc.titleClinical practice guidelines for the diagnosis and treatment of cutaneous leishmaniasis in Turkey
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu